XML 87 R70.htm IDEA: XBRL DOCUMENT v3.10.0.1
INCOME TAXES (Effective Tax Rate Reconciliation) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]      
U.S. Earnings/(Loss) before income taxes $ 2,338 $ 2,280 $ 3,100
Non-U.S. Earnings before income taxes 3,630 2,851 2,815
Earnings Before Income Taxes 5,968 5,131 5,915
Effective Income Tax Rate Reconciliation, Amount [Abstract]      
U.S. statutory rate, Amount 1,253 1,796 2,070
Deemed repatriation transition tax, Amount (56) 2,611 0
Deferred tax remeasurement, Amount 0 285 0
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 94 0 0
Foreign tax effect of certain operations in Ireland, Puerto Rico and Switzerland (202) (561) (442)
U.S. Federal valuation allowance release 119 0 (29)
U.S. Federal, state and foreign contingent tax matters, Amount (55) 72 87
U.S. Federal research based credits, amount (138) (144) (144)
Non-tax deductible goodwill related to diabetes divestiture, Amount 0 4 34
Non-tax deductible U.S. Branded Prescription Drug fee, Amount 21 52 52
Non-tax deductible research and development charge, Amount 17 266 100
Puerto Rico excise tax, amount (152) (131) (131)
Domestic manufacturing deduction, amount 0 (78) (122)
State and local taxes (net of valuation allowance), amount 67 77 23
Foreign and other, Amount 53 (93) (90)
Provision for Income Taxes $ 1,021 $ 4,156 $ 1,408
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
U.S. statutory income tax rate 21.00% 35.00% 35.00%
Deemed repatriation transition tax, Percent (0.90%) 50.90% 0.00%
Deferred tax remeasurement, Percent 0.00% 5.60% 0.00%
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 1.60% 0.00% 0.00%
Foreign tax effect of certain operations in Ireland, Puerto Rico and Switzerland, Rate (3.40%) (10.90%) (7.50%)
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent 2.00% 0.00% (0.50%)
U.S. Federal, state and foreign contingent tax matters, Rate (0.90%) 1.40% 1.50%
U.S. Federal research based credits, Rate (2.30%) (2.80%) (2.40%)
Non-tax deductible goodwill related to diabetes divestiture, Rate 0.00% 0.10% 0.60%
Non-tax deductible U.S. Branded Prescription Drug Fee, Rate 0.30% 1.00% 0.90%
Non-tax deductible research and development charge, Rate 0.30% 5.20% 1.70%
Puerto Rico excise tax, Rate (2.60%) (2.60%) (2.20%)
Domestic manufacturing deduction, Percent (0.00%) (1.50%) (2.10%)
State and local taxes (net of valuation allowance), Rate 1.10% 1.50% 0.40%
Foreign and other, Amount 0.90% (1.90%) (1.60%)
Effective Income Tax Rate Reconciliation, Percent 17.10% 81.00% 23.80%